With the rapid rise of the specialty drug market, manufacturers are increasingly relying on new advances used by patient hubs to boost their levels of patient engagement.
Dhaval Shah and Simran Mittal, PhD, CitiusTech
Advertisement
Articles by Dhaval Shah and Simran Mittal, PhD, CitiusTech
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Mark Cuban Cost Plus Drug Company Adds Starjemza to Prescription Drug Portfolio
2
The New Pharma Equation: How DTP, DTC, and DTE are Re-Wiring Healthcare Around Patients
3
Direct-to-Patient (DTP): Who Benefits - and Why It’s Different
4
Cencora Reveals $1 Billion Investment Plan Enhancing US-Based Distribution Network
5
